Innogenetics NV - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Innogenetics NV. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Innogenetics NV. The Group's principal activities are to provide diagnostic and therapeutic products using biotechnological research. The Diagnostics business focuses on infectious diseases, genetic testing, and neurodegeneration of many common diseases like HIV, Syphilis, Mycobacteria, Alzheimer's disease, HLA Class I and II etc. The Therapeutics division develops vaccines for infectious diseases for which current treatment options are limited. Their products include vaccines for Hepatitis B, Hepatitis C, Pulmonary Edema and other hard-to-heal wounds. The Group has operations in the United States, Germany, Spain, Italy, France, Brazil and the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report